HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients

Clinical trial NCT04986176 · UNKNOWN

Trial details

NCT number: NCT04986176
Sponsor: Applied Biology, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Respiratory Infection

Start date: 2022-04-15
Primary completion: 2022-12-31
Enrollment: 602

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.